OREANDA-NEWS. The World Health Organization (WHO) is ready to continue evaluating the Russian Sputnik V vaccine for emergency use and is awaiting full data for analysis, the organization’s press service told RIA Novosti.

Earlier, the head of the Russian Direct Investment Fund (RDIF) Kirill Dmitriev said that the fund expects that WHO will approve the Sputnik V vaccine in the next couple of months, and expects that a group of inspectors will soon arrive in Russia.

"The World Health Organization welcomes the signing by RDIF of all legal agreements that are required to evaluate a vaccine for listing for emergency use. We expect to receive full data to analyze and continue the evaluation process," the agency told WHO.

The day before, in the account of Sputnik V on Twitter, it was reported that the preliminary assessment of the vaccine is entering the final stage and a group of WHO inspectors will soon visit Russia.

Earlier in an interview with RIA Novosti, WHO senior researcher Sumiya Swaminathan said that the dispatch of the inspection would depend on the availability of free experts, as well as on the epidemiological requirements in the country.

The Kremlin expects that the domestic vaccine against coronavirus "Sputnik V" will receive registration in Europe, which it should have had a long time ago, the press secretary of the Russian President Dmitry Peskov told reporters.

"We expect that the registration of the Russian vaccine in Europe will be completed, and that our vaccine will receive the registration that, in fact, it should have received, from our point of view, a long time ago," he said.

The Kremlin believes that now there are technical formalities left in Europe for the registration of Sputnik V, Russian presidential press secretary Dmitry Peskov told reporters.